Drug factory · FDA FEI 3003098680
CSL Behring GmbH
Emil von Behring Strasse 76, Marburg, Germany
Problems found, fixed voluntarily at FDA's last inspection, Mar 18, 2010.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
1 drug inspection on record since 2010: 0 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Albutrepenonacog Alfa | Makes it | CSL Behring Lengnau AG | 69911-864, 69911-865, 69911-866 +2 |
| Factor Xiii Concentrate (human) | Makes it | Csl | 63833-518 |
| Fibrinogen Human | Makes it | Csl | 63833-891, 63833-892 |
| Lonoctocog Alfa | Makes it | CSL Behring Lengnau AG | 69911-474, 69911-475, 69911-476 +4 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Mar 18, 2010 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: manufacture.